Communication Fosters Consensus, Learning and Discussion Drive Development
Secretary Li Xinguo, Financial Director Zhang Hui, Deputy General Manager Yang Ming, and managers from relevant departments. During the event, delegates visited the A Centennial Exhibition Hall of China Biological Products and the R&D Center. Through valuable exhibits and advanced research facilities, they gained deep insights into the century-long developm...
View More +Breaking News! BIBP’s Polio Vaccine passed WHO Prequalification again
On July 18, the 5-dose Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains (sIPV), independently developed by the Beijing Institute of Biological Products Co., Ltd. (BIBP), part of the China National Biotec Group Company Limited (CNBG), officially passed prequalification (PQ) from the World Health Organization (WHO). This marks another milestone in the internation...
View More +
Africa CDC Delegation Visits BIBP
On December 17, a delegation from the Africa CDC, led by Director Jean Kaseya and accompanied by Wang Lili, Associate Researcher at the Global Public Health Center of the Chinese Center for Disease Control and Prevention, along with a group of 12 people, visited the Beijing Institute of Biological Products Co., Ltd. (BIBP), part of the China National Biotec Group Company Li...
View More +
Empowering Growth, Gaining momentum
internal trainer special training course from August 22 to 23, 2024. A total of 57 internal trainers participated in the training. previous two internal trainer training courses organized by BIBP focused on the course teaching, design, and presentation skills. This training course focused, and guide the trainees to develop a 3 to 8 minu...
View More +
Facing Challenges, Maintaining Composure, Strengthening Confidence, Taking Responsibility
▲ Zhang Yuntao, Chief Scientist of China National Pharmaceutical Group Co., Ltd, Vice President of CNBG, and General Manager of BIBP, delivered a working speech Regarding the development direction of BIBP in the second half of the year, Zhang Yuntao put forward the following requirements and hopes...
View More +
Sun Is Fierce, You Shine Brighter!
Where the sun blazes the earth in fervent dance Some fear not the furnace of high noon Embracing the sun's scorch Beijing in June 2024 has entered a "scorching mode." The outdoor temperature has approached 40°C, and the blazing sun is an extreme test for the operation of various equipment and facilities within the . To ensure the safe and smooth o...
View More +
BIBP Holds 2024 'Cost Reduction and Efficiency Enhancement' Special Work Launch Meeting
(CNBG) Jing Yumei relayed the spirit of the special work deployment meeting on “Cost Reduction and Efficiency Enhancement”organized by CNBG, and delivered a rousing mobilization speech. She emphasized that all departments must cultivate a mindset of "Living a Frugal Life" and improve quality and efficiency while ensuring quality, safety and compliance...
View More +
Good News | National Innovation Platform + 1
Recently, Beijing Institute of Biological Products Co., Ltd. (BIBP), a subsidiary of China National Biotec Group Company Limited which is subordinated to China National Pharmaceutical Group Co., Ltd, has been accredited as the 2023 (30th batch) National Enterprise Technology Center. This recognition reflects the acknowledgement of BIBP's high-level scientific and techn...
View More +
To Pursuit Excellence Begins Starting with a Change in Yourself! New roles, New Perspectives, New Thinking!
In order to improve the comprehensive quality and business ability of middle and basic managers, during November 6-12, 2023, CNBG Beijing Institute of Biological Products (BIBP) organized two periods of training called "Leapfrog Plan", in which 110 managers have participated. The training was delivered by Mr. Lin Guang, Secretary of the Party Committee, and hosted by M...
View More +
Concentrate “New” Force and Set Sail | The Orientation for New Employees of Beijing Institute of Biological Products has been Successfully Finished
On August 25th, 2023, the one-week orientation for new employees of Beijing Institute of Biological Products (hereinafter referred to as "BIBP") came to a successful conclusion. The purpose of this activity is to help new employees know the company's hundred-years history, understand the company's culture, business processes and various rules and regulations, and to help th...
View More +
The Delegation from African Medicines Agency, African Medicines Quality Forum and Bill & Melinda Gates Foundation Visited BIBP
On July 2nd,2023, Mr. Michel Sidibé, Envoy of African Medicines Agency (AMA), Mr. Bonaventure Chilinde, Chairperson of African Medicines Quality Forum (AMQF), and Xu Fujie and Yang Jianyue, Deputy Director of the Beijing Representative Office of Bill & Melinda Gates Foundation, and others, for total 7 people visited Sinopharm CNBG, Beijing Institute of Biological Produc...
View More +
BIBP’s Group ACYW135 Meningococcal Polysaccharide Vaccine was approved for marketing
Big News! BIBP’s Group ACYW135 Meningococcal Polysaccharide Vaccine was approved for marketing! It enriches CNBG’s vaccine products for human use and provides more protection for the prevention of epidemic meningitis in China! Recently, Sinopharm CNBG, Beijing Institute of Biological Products Co., Ltd. (h...
View More +
Congratulations! BIBP Has Been Approved As A National Post-doctoral Research Workstation
Big Moments! Beijing Institute of Biological Products Co., Ltd. has reached an important milestone—— BIBP has been successfully approved as national post-doctoral research workstation This is an important point in the transformation and upgrading development of BIBP On May 12th, Ministry of Human Resources and Social Security o...
View More +
Glad Tidings! Top 100 in 3 Lists!
On December 22, Beijing Enterprise Confederation and Beijing Enterprise Directors Association released the “1+5" lists of 2022 Top 100 Beijing Enterprises, 2022 Top 100 Beijing Manufacturing Enterprises, and 2022 Top 100 Beijing High-tech Enterprises. Beijing Institute of Biological Products (BIBP) is included in these lists. Rank 15 among 2022 Top 100 Beijing Ente...
View More +
Significant Progress! WHO Extends the Recommended Age of Use of COVID-19 Vaccine (Vero Cell), Inactivated of SINOPHARM CNBG Beijing Institute of Biological Products Co., Ltd. to Over 60 Years Old
Recently, WHO has extended the recommended age of use of COVID-19 Vaccine (Vero Cell), Inactivated developed and produced by SINOPHARM CNBG Beijing Institute of Biological Products Co., Ltd. (BIBP) to over 60 years old, which means that the safety and efficacy of the vaccine for people aged 18 and over have been recognized by WHO. ▲The recommended age o...
View More +Contact us
